|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DATA RESEARCH ASSOCIATES INC, 10-Q, 2000-08-02 |
Next: CELLEGY PHARMACEUTICALS INC, S-8, 2000-08-02 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE FORM 10-Q
FOR THE NINE MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-END> JUN-30-2000
<CASH> 16,707
<SECURITIES> 983
<RECEIVABLES> 7,877
<ALLOWANCES> 83
<INVENTORY> 153
<CURRENT-ASSETS> 27,127
<PP&E> 15,374
<DEPRECIATION> 9,993
<TOTAL-ASSETS> 38,416
<CURRENT-LIABILITIES> 9,253
<BONDS> 0
0
0
<COMMON> 56
<OTHER-SE> 26,966
<TOTAL-LIABILITY-AND-EQUITY> 38,416
<SALES> 20,422
<TOTAL-REVENUES> 20,422
<CGS> 6,340
<TOTAL-COSTS> 19,769
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (844)
<INCOME-PRETAX> 1,497
<INCOME-TAX> 475
<INCOME-CONTINUING> 1,022
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,022
<EPS-BASIC> .21
<EPS-DILUTED> .21
</TABLE>
|
|